- Screening assays
-Investigational assays
-The tools we offer to help you measure, and investigate, mitochondrial toxicity.
Every year, dozens of pharmaceutical compounds are withdrawn from the market due to adverse effects not discovered during the preclinical or clinical testing. Many of these adverse effects are subtle and do not lead to visible histopathology, but often lead to mitochondrial dysfunction. Therefore, screening for mitochondrial toxicity in the early development stages of a drug is essential.
This in-depth guide outlines the tools available to analyze mitochondrial toxicity.
Download now
Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.